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ABSTRACT 
Improved electron micrographs of the shadow-cast  bovine flbrinogen molecule 
have been obtained establishing its general morphology and dimensions in the dry 
state. It consists of a linear array of 3 nodules held together by a very thin thread 
which is estimated to have a diameter of from 8 to 15 A, though it is not clearly 
resolved.  The  two end  nodules  are  alike  but  the  center one is slightly smaller. 
Measurements of shadow lengths indicate that nodule diameters are in the range 
50 to 70 A. The length of the dried molecule is 475  =t= 25 A. 
Adopting the molecular volume from previous physical chemical data and  the 
general morphological features and length from electron microscopy, we calculate 
the diameters of the end nodules to be 65 A and the center one as 50 A. The model 
of the molecule so obtained is consistent with the electron microscopical observa- 
tions and the data from physical chemistry. 
]'he intermediate polymers formed when fibrinogen is activated with thrombin 
were also examined and  found  to be end-to-end aggregates of altered fibrinogen 
molecules which shrink in length during the process.  Intermediate polymer lengths 
are from 1000 to 5000 A. 
The nodular nature of fibrinogen,  its shrinkage and end-to-end aggregation on 
polymerization permits us to deduce an explanation for the system of cross-bands 
previously observed in stained fibrin fibrils 
INTRODUCTION 
The  extensive  literature  dealing  with  the 
fibrinogen  molecule  and  its  conversion  to  fibrin 
has  been  reviewed  at  length  by  Scheraga  and 
Laskowski  (1)  and  in  a  briefer  discussion  by 
Waugh  (2).  The molecular weight of fibrinogen is 
well  established  from  physical  chemical  data  at 
330,000  to  340,000  (3).  That  the  molecule  has  a 
high  asymmetry  ratio  is  also  firmly  established, 
but the dimensions cannot be deduced  without in- 
formation  regarding  the  molecular  morphology 
which is obtainable only from electron microscopy. 
In the first attempts  to study  the fibrinogen mole- 
cule with  the  electron microscope, Hall  (4,  5)  ob- 
served  nodous  filaments  "like a  string  of  beads," 
but units were so entangled that it was not possible 
to establish a  unique length for the molecule. The 
high  concentration  in  his  preparative  procedure 
was  necessary  to  cover  the  somewhat  similar 
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texture  of  the  supporting  film. Later,  Porter  and 
Hawn (6)  failed to confirm Hall's observations and 
proposed  an  oblate  ellipsoidal  model  for  the 
fibrinogen  molecule  which  seemed  to  have  some 
advantages  in  explaining  their  observed  cross- 
striations  in fibrin  (7).  This  model was  not,  how- 
ever,  consistent  with  the  accepted  interpretation 
of  the  physical  chemical  data  (8),  and  their  pro- 
posed structure  for fibrin based on this model was 
inconsistent  with  later  electron  micrographs  of 
fibrin made by Hall (5). Still later, Mitchel (9)  also 
failed  to  confirm Hall's observations  and  reported 
finding  only  spherical  particles.  The  presence  of 
nodose  filaments  in  fibrinogen  solutions  was 
eventually  confirmed  by  Siegel,  Mernan,  and 
Scheraga  (10)  whose  technique  was  sufficiently 
improved  that  they  could  discern  individual 
"strings of beads,"  but  there  was  some confusion 
with  the  substrate  texture  and  probably  some 
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disruption  of  structures  due  to  drying.  Conse- 
quently,  though  their  micrographs  were a  signifi- 
cant  improvement,  they  were  not  able  to  find  a 
unit which would correspond  to the molecule that 
existed  in  the  presumably  highly  monodisperse 
fibrinogen  solutions.  Discrete  fibrinogen  mole- 
cules  were  finally  observed  clearly  by  Hall  (11) 
using a  technique  that eliminates substrate  struc- 
ture  (12-14).  Since  the  preliminary  report  (11) 
we have gathered quantitative supporting data on 
the structure of the fibrinogen molecule and studied 
aspects of the polymerization process. 
Probably  the most significant result in previous 
work on  the polymerization process  has  been  the 
observation  by  physical  chemical  methods  of 
intermediate  polymers  very  much  thinner  than 
fully  polymerized  fibrin  fibrils  and  with  lengths 
up to about 4000 A  (I). The apparent diameter of 
the polymer  is,  however,  greater  than  the  width 
of  the  hydrodynamic  ellipsoidal  model  generally 
used, which has been interpreted  to mean that the 
polymer  grows  by  staggered  side-to-side  associa- 
tion  (15).  Previous  electron  microscope  observa- 
tions  confirmed  the  existence  of  such  a  polymer 
and  indicated  that  the  aggregation  was  pre- 
dominantly  end-to-end,  but  did  not  rule  out  the 
possibility of some lateral overlapping  (10,  16). 
The  most  striking  aspect  of  fully  polymerized 
fibrin  fibrils  in  the  electron  microscope  is  the 
existence  in  stained  specimens  of  regular  cross- 
striations  with  a  period  of  about  230  A  as  first 
observed by Hawn and Porter (7). Later, Hall (5) 
showed  that  between  the  heavily  stained  bands 
there  existed  a  lighter  secondary  stained  band. 
No  acceptable  scheme  has  been  proposed  to  ac- 
count  for  the  observed  structure  on  the basis  of 
the  structure  of  fibrinogen.  As  a  result  of  the 
studies  to  be described, we have devised a  model 
which accounts for the observed bands  and is con- 
sistent with other relevant data. 
Materials and Methods 
We have  obtained  excellent micrographs  of bovine 
fibrinogen,  directly  from  commercial  Fraction  I 
(Pentex) and from repurified fibrinogen made by D. F. 
Waugh  according  to  the  method  of  Laki  (17).  The 
latter shows a  higher proportion of recognizable mole- 
cules.  The  repurified  material  was  stored  frozen  and 
later thawed under tap water prior to use.  In any case, 
the material was dialyzed for 24 to 48 hours against 0.1 
per  cent (NH4)2C03 adjusted  to pH 9.5 with  NH4OH 
to  give  a  stock  solution  of  fibrinogen  of  5  mg./ml. 
For  electron  microscopy various  concentrations  of 
fibrinogen were used,  but  for  atypicaI  experiment  a 
solution would contain 0.15 mg./ml, of bovine fibrino- 
gen plus 0.06  mg./ml, of polystyrene spheres of mean 
diameter  880  A.  The  material  was  sprayed  on  to  a 
freshly cleaved mica surface from a high pressure spray 
gun,  shadow-cast with Pt at a  shadow-to-height ratio 
of  about  10:1,  backed  with  SiO  and  collodion,  and 
stripped  on  water  as  previously  described  (11-14). 
Micrographs weremade with anR. C. A. Type EMU3-B 
at  a  magnification of about  15,1300. The best popula- 
tions of intact molecules were obtained when the mica 
surface  was  double-sprayed  with  fibrinogen  and  0.2 
per cent formalin, or when the formalin was added  to 
the solution. 
In the polymerization experiments we used a sample 
'  of thrombin obtained from Dr. Walter H. Seegers. The 
sample had an activity of 130 units per rag.  (Its original 
activity was 640 units per mg. when first obtained some 
15 years ago.)  In a typical experiment, bovine fibrino- 
gen and thrombin in 0.1 per cent (NH4)2CO3 at pH 9.5 
were mixed so that the concentration of fibrinogen was 
about 1.5 mg./ml, and the thrombin was 0.4 units/ml. 
(0.003 mg./ml.). Samples were taken at intervals vary- 
ing from 30 seconds  up to 2 or 3 minutes, diluted by a 
factor  of  10  with  buffer,  and  sprayed  immediately. 
Best intermediate polymers were observed for clotting 
times between 30 and 60 seconds. 
OBSERVATIONS AND  RESULTS 
Molecular Morphology.--A  micrograph  showing 
the  typical particles  observed  in fibrinogen prep- 
arations  is reproduced  in Fig.  1.  There are triads, 
A, which we identify with the fibrinogen molecule, 
dyads, B, and monads, C, which we believe are the 
result  of  breakage  probably  due  to  mechanical 
rupture  during  drying.  Designated  D  is  also  a 
string  of  4  nodules,  but  strings  of  more  than  3 
nodules  are  extremely  rare  except in areas where 
there  is  very  obvious  clumping  due  to  high  con- 
centration. 
A  triad  is  usually  straight,  although  the  con- 
necting thread is extremely thin.  The diameter of 
the thread is estimated at 8  to  15 A--close to  the 
resolution  limit  of  the  method.  The  two  end 
nodules appear  to be identical but  the center one 
is  a  little  smaller.  As  can  be  seen  in  the  figure, 
doublets  are  more  nearly  the  length  of  a  triad, 
suggesting that  in this case they are formed  by a 
splitting  off of  the  center  nodule  leaving  the  end 
two attached  by a  thread  which,  however,  is not 
clearly seen. 
In Table I  are tabulated  the  results  of particle 
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TABLE I 
Particle  Counts From  Electron Micrographs of Bovine 
Fibrinogen 
Type of particle 
Pentex bovine Fraction I 
Waugh's purified bovine 
fraction  I  double- 
sprayed  with  formal- 
dehyde .............. 
o  oo 
551  244 
366  356 
ooo 
267 
943 
oooo  Iooooo 
4  10 
2  0 
mercial bovine Fraction I, and another with highly 
repurified  Fraction  I  which  was  stabilized  with 
formaldehyde  while  sprayed.  In  both  cases  it  is 
seen  that  strings of more  than 3  nodules are  ex- 
tremely rare and can be dismissed as representing 
the  fibrinogen molecule.  In  the  first  case,  triads 
are a little more numerous than dyads and monads 
are  very  numerous,  as  would  be  expected  in  a 
relatively impure material. In the second instance, 
triads  constitute  about  73  per  cent  of  the  total 
material if we count  one monad and one dyad as 
equal  to  one  triad.  It  is  remarkable  that  the 
number of  monads  and  dyads  is  practically  the 
same, strongly suggesting that they are formed by 
a  splitting of one nodule from a  triad due to dis- 
ruptive forces of drying. We conclude from  these 
data that the  triad represents the fibrinogen mol- 
ecule. 
Although in most micrographs  the  nodules ap- 
pear spherical, there is frequently evidence of sub- 
structure within them. Since, however, we have not 
clearly  resolved  these  aspects,  we  shall represent 
them diagrammatically as spherical. It seems very 
likely,  however,  that  if  the  resolution  of  the 
method  could  be  improved  each  nodule  would 
display  a  higher  degree  of  complexity.  All  the 
micrographs shown are slightly underfocused. 
Molecular  Weight.--Katz  et  al.  (18)  gave  a 
molecular weight  of 340,000 from  light-scattering 
and a  little later from a  consideration of sedimen- 
tation, diffusion, and viscosity, Shulman (3)  gave 
a  value of  330,000  +  10,000.  As  a  check  in  the 
present  study  we  ran  purified  bovine  fibrinogen 
in the centrifuge according to the semi-equilibrium 
method  of  Archibald  (19),  which  method  has 
been  described  in  detail  elsewhere  (20).  The 
average  of  two  runs gave  a  molecular  weight  of 
324,000 which is sufficiently close to  the accepted 
value of Shulman to establish that we are dealing 
with  essentially  the  same  molecule.  We  cannot 
obtain  a  more  accurate  molecular  weight  (or 
volume) from  electron microscopy at  the present 
time  and  therefore  assume  Shulman's molecular 
volume of 38.7  ×  10  -2° cm.  ~ (calculated from  the 
anhydrous molecular weight plus  the  density)  to 
be used  in conjunction with  electron microscopic 
morphology in working out a  molecular model. 
Dimensions.--Apparent  lengths  of  shadowed 
fibrinogen molecules  were  measured  from  prints 
at  a  magnification  of  about  100,000.  A  set  of 
results are  represented  graphically in Text-fig.  1. 
Eighty-seven per  cent  of  the  lengths  are  in  the 
interval 450 to 520 A, which is a  reasonably sharp 
peak  considering the  disruptive  forces  of  drying. 
A  number or  weight  average  from  these  data  is 
probably not significant since the molecules are in 
all  likelihood homogeneous  as  to  length  in  solu- 
tion  and  the  distribution of  lengths  observed  is 
probably  due  to  shrinkage  during  drying.  We 
would  think that  the  significant length would be 
either the most frequently occurring or the maxi- 
mum observed, though some stretching might con- 
ceivably occur. In any case, whether we  take  the 
significant  length  as  the  most  frequent  or  the 
maximum, we have a value between 500 to 520 A. 
This applies to the apparent length of the shadowed 
particle which has a  cap of metal over both ends 
which could increase the apparent length by any- 
thing from  20  to  50 A.  As a  result of  these  con- 
siderations,  we  conclude  that  the  length  of  the 
molecule is 475  :t= 25 A. 
In  working  out  a  model  for  the  fibrinogen 
40- 
N 
I  30-  LENGTHS OF SHADOWED 
FtBRINOGEN MOLECULES 
20- 
I0-  F-~ 
i 
o  '  2;0  ,,oo  .;o 
LENGTH  IN A 
TEXT-FIo. 1.  Histogram  showing  distribution  of 
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TEXT-FIG. 2.  Model of flbrinogen molecule deduced 
from  the  electron  microscope  observations  and  the 
molecular volume from physical chemical data. 
molecule we  have  taken  the  following  considera- 
tions into account: 
1.  The over-all length is 475  ±  25 A. 
2.  There are  3 nodules of which the outer two 
are equal  and the middle one is smaller. 
3.  We  cannot  measure  the  diameter  of  the 
nodules with sufficient accuracy for volume calcu- 
lations but we estimate from shadow  lengths that 
they are in the range 50 to 70 A. 
4.  From  measurements of  shadow  lengths  we 
estimate that the diameter of the center nodule is 
about 80 per cent that of the end ones. 
5.  The  nodules are  held  together  by a  thread 
which is not clearly resolved.  Since we have been 
able in general clearly to resolve  rod-shaped mole- 
cules  with diameters in the  15  to 20 A range, we 
estimate  that  the  thread  is  probably about 8  to 
15 A in diameter. The volume contributed by this 
element is  small compared  to  the  volume of  the 
nodules. 
6.  We  adopt  Shulman's figure  for  the  volume 
(anhydrous) of 38.7 ×  104 A  3 and calculate the di- 
ameters of the nodules (rounded off to 5 A) from 
this  volume.  The  resulting  diameters  are  con- 
sistent with the estimates from electron microscopy 
given in 3 above. 
The resulting model is shown in Text-fig. 2.  It 
is interesting to  note that  among the variety of 
models  to  which  Shulman attempted  to  fit  the 
physical chemical data a  string of  4  beads bears 
the  closest  resemblance  to  our  result,  and  his 
figure for the length is 430 A. Ellipsoidal models 
are much too long and much too thin. We believe 
that  the  model of  Text-fig.  2  is  consistent with 
all the significant data at present available at this 
level of  dimensions. There  are  undoubtedly lea- 
• tures  of  substructure  which  have  not  yet  been 
resolved. 
Polymerization  o[  Fibrinogen.~-Typical  inter- 
mediate  polymers  prepared  as  described  under 
Methods are shown in Fig. 2 and at higher magni- 
fication in Fig.  3.  These  strands can be  seen  to 
consist of  strings of  nodules, which however, are 
much closer  together than they are in fibrinogen. 
Polymer lengths are  from  1000 to  5000  A.  The 
interval occupied by 3 successive  nodes is usually 
less than 300 A. (The apparent size of the nodules 
in Figs.  1 and 3 are not to be compared quanti- 
tatively since  apparent size depends on quantity 
of  metal,  direction  of  shadowing,  and  other 
factors.)  It  is  not generally possible to  pick  out 
the precursor fibrinogen molecules  in these poly- 
mers because  there  is  some  distortion of  typical 
triads and the  difference  between the center and 
end nodules is not always evident. What appears 
to be two clear cut triads end-to-end is indicated 
in Fig. 3 a.  The evidence is definitely for end-to- 
end polymerization. 
DISCUSSION 
At the level of dimensions given in Text-fig. 2 
we have a model of the fibrinogen molecule which 
for the first time fits all of the pertinent data and 
provides a  substantial basis for the interpretation 
of  physical  chemical  and  other  data  aimed  at 
further  elucidation of  the  structure.  It is almost 
certain that the nodules represented in outline con- 
tain incompletely resolved  substructure•  No  evi- 
dence  has  been  obtained  or  would  be  expected 
from this electron microscope  study of small pep- 
tides which might be split off in the activation by 
thrombin. The  central nodule is  certainly much 
too  big  to  represent  such  low  molecular weight 
products as have been observed (1). The absence 
of dimers and higher order polymers in fibrinogen 
preparations is to be noted and probably indicates 
a strong repulsion between the molecules. Whether 
the thread-nodule relationship in the triad is like a 
ball and chain or like a  string of beads cannot be 
deduced  from  the  present  evidence.  The  occur- 
rence of diads with the middle nodule apparently 
split off would suggest that the thread passes  con- 
tinuously through the center region. 
The observations of the intermediate polymer of 
fibrin  clarify  previous  concepts  and  suggest  a 
plausible sequence between  the  fibrinogen mole- 
TExT-Fla. 3.  Model devised  to  account  for  the 
observed cross-striations in fully polymerized fibrin as 
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cule and  the  observed banded structure in fibrin 
shown in Fig. 4. Since we cannot distinguish a unit 
which might be termed a  fibrin molecule in Fig. 
4, our model for fibrin is speculative and diagram- 
matic. In making such a model we must take into 
account tile following results, however: 
1.  The polymerization is end-to-end which rules 
out the suggested  side-to-side mode suggested by 
Ferry, Katz, and Tinoco (15). 
2.  There is a shrinkage of the fibrinogen in the 
polymer down to about one-half its original length. 
3.  In such  a  polymer, after  shrinkage,  the  di- 
ameter is essentially that of  the  nodules, that  is 
50  to  65  A.  This is  in excellent agreement with 
hydrodynamic data  (21).  Lengths are also  in the 
range  expected.  The  staggered  model  was  sug- 
gested partly to account for the fact that the ellip- 
soidal model had a diameter of 30 A which was too 
small  to  account for  the  diameter  of  the  inter- 
mediate polymer. 
4.  The triad morphology lends itself  readily to 
account for the system of heavy and light bands 
observed in stained fibrin. 
With  these  considerations in mind and on  the 
assumption that the fibrinogen particle maintains 
some degree of integrity in the process,  we propose 
the model shown in Text-fig. 3 to account for  the 
observed band structure in fibrin. The dimensions 
are  taken  approximately from  the  relative band 
dimensions of fibrin shown in Fig. 4. 
The  longitudinal  shrinkage  of  the  fibrinogen 
molecule in the  conversion is  perhaps  suggestive 
of  the syneresis effects  that are observed in gross 
clots.  We  do  not  believe,  however,  that  these 
effects  are  connected. Syneresis appears  to  result 
from  strong  interaction  between  large  fibrils  in 
an  advanced  stage  of  dotting  where  there  is  a 
large amount of  side-to-side  aggregation. In elec- 
tron  micrographs  of  stained fibrin clotted  under 
dose  to  physiological  concentrations  one  sees 
bundles of fibrils lying side-by-side with the stria- 
tions in register suggestive of strong lateral attrac- 
tions in final  stages of the clot.  Under conditions 
designed  to  produce  the  intermediate  polymer 
there is apparently little tendency for lateral aggre- 
gation, but lateral forces must come strongly into 
play as the clot develops. 
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EXPLANATION  OF  PLATE  l 
FIG. 1,  Fibrinogen molecules from repurified bovine Fraction I. The intact molecules are the triads, designated 
A. Dyads, B, and monads, C, are believed to be fragments produced by the disruptive forces during drying. Strings 
of more than 3 nodules such as at D  are very rare. Magnification, 156,000. 
FIG. 2.  Intermediate polymers consisting of end-to-end aggregations of fibrinogen molecules produced  by the 
action of thrombin. Magnification, 100,000. 
FIG. 3.  Same as Fig. 2, but at higher magnification. Indicated in a by the arrow are two fibrinogen triads which 
have come together end-to-end and shrunk in length. Polymers in b and c are from other parts of the field.  Mag- 
nification, 150,000. 
F~c. 4.  Segment of a typical fully polymerized fibrin fibril stained with phosphotungstic acid. The axial period 
is about 230 A and consists of alternating heavily and lightly stained bands designated A  and B, respectively. 
Magnification, 180,000. THE  JOURNAL  OF 
BIOPHYSICAL AND BIOCHEMICAL 
CYTOLOGY 
PLATE  1 
VOL.  5 
(Hall and Slayter: Fibrinogen molecule) 